<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 1999
CELANESE AG
(Exact name of registrant as specified in its charter)
CELANESE CORPORATION
(Translation of registrant's name into English)
D-65926 Frankfurt am Main, Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F
------ ------
Indicate by check mark whether the registrant by furnishing
the information contained in this Form is also thereby furnishing
the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes No X
------ ------
If "Yes" is marked, indicate below the file number assigned to
the registrant in connection with Rule 12g3-2(b): 82- .
--------
Page 1
<PAGE> 2
CELANESE AG
On December 15, 1999 Celanese AG, a stock corporation organized
under the laws of the Federal Republic of Germany (the
"Company"), issued a Press Release in which Celanese AG announced
its decision to hedge the financial exposure resulting from the
approximately 5.1 million Stock Appreciation Rights it expects to
grant to its employees, which Press Release is attached as
Exhibit 99.1 hereto and incorporated by reference herein.
Any statements contained in the Exhibit hereto that are not
historical facts are forward-looking statements as defined in the
U.S. Private Securities Litigation Reform Act of 1995. Words such
as "believe," "estimate," "intend," "may," "will," "expect," and
"project" and similar expressions as they relate to the Company
are intended to identify such forward-looking statements. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements. All forward-looking statements are
subject to various risks and uncertainties that could cause
actual results to differ materially from expectations. These risk
factors are discussed more fully in the Company's filings with
the U.S. Securities and Exchange Commission, including the
Company's Registration Statement on Form F-1. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of their dates.
Page 2
<PAGE> 3
EXHIBITS
Exhibit No. Exhibit
----------- -------
99.1 Press Release, dated
December 15, 1999
announcing Registrant's
decision to hedge financial
exposure related to Stock
Appreciation Rights
Page 3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
CELANESE AG
(Registrant)
By: /s/ P. W. Premdas
Name : Perry W. Premdas
Title: Member of the Management Board
(Chief Financial Officer)
Date: December 15, 1999
Page 4
<PAGE> 5
EXHIBIT INDEX
Exhibit No. Exhibit
----------- -------
99.1 Press Release, dated
December 15, 1999
announcing Registrant's
decision to hedge financial
exposure related to Stock
Appreciation Rights
<PAGE> 1
[CELANESE LOGO]
PRESS RELEASE
Celanese AG
Your contacts: Corporate Center
Building F 821
Dr. H.-B. Heier D-65926 Frankfurt
am Main
Tel. +49(0)69 305-7112
Fax +49(0)69 305-84160
Phillip Elliott
Tel. +49(0)69 305-33480
Fax +49(0)69 305-17082
December 15,1999
- --------------------------------------------------------------------------------
CELANESE AG TO COVER 1999 INCENTIVE AND EQUITY PARTICIPATION PROGRAMS
Celanese has decided to hedge the financial exposure resulting from the
approximately 5.1 million Stock Appreciation Rights (SARs) it expects to grant
to its employees and management as part of long-term stock-based incentive
programs. From time to time from December 15, 1999 onwards, the company will
therefore purchase options covering Celanese AG shares. The base price of the
SARs is (euro) 16.3705 per share, calculated on the basis of the average share
price during the first 20 days of trading, with employees being entitled to
receive in cash the difference between the base price and the price of Celanese
shares on the date of exercise of the SARs.
